Market Cap 2.44B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 6.66
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.85
Volume 2,496,700
Avg Vol 4,636,876
Day's Range N/A - N/A
Shares Out 255.54M
Stochastic %K 7%
Beta 0.55
Analysts Strong Sell
Price Target $20.55

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
Paulzk
Paulzk Aug. 24 at 2:42 PM
$BCRX pennies from heaven
0 · Reply
Pharm_Hand
Pharm_Hand Aug. 24 at 2:37 PM
$BCRX Ghouls and batmen. It's a great chart for Halloween but that's about it.
0 · Reply
WKNDatBERNIES
WKNDatBERNIES Aug. 24 at 1:36 PM
$BCRX up to $10 or down to $9. Either way, let’s get moving
1 · Reply
Paulzk
Paulzk Aug. 24 at 1:07 PM
$BCRX Go gold go!
0 · Reply
buy_undervalued_stocks
buy_undervalued_stocks Aug. 24 at 1:05 PM
$BCRX Down again...
0 · Reply
Paulzk
Paulzk Aug. 24 at 12:57 PM
$BCRX Interesting solar evaluation https://www.youtube.com/watch?v=3MaOu7I2oPc
0 · Reply
BirdStar
BirdStar Aug. 24 at 12:47 PM
1 · Reply
Paulzk
Paulzk Aug. 24 at 12:43 PM
$BCRX 10 billion to build an oil refinery in Asia 300 billion to build a refinery in the US. That is a huge problem. No wonder the construction keeps stalling it makes no economic sense.
1 · Reply
Paulzk
Paulzk Aug. 24 at 12:36 PM
$BCRX To build the refineries we need it would take 19.8 trillion dollars and at least 4 years for each permit approval and 3 to 5 years for the construction. 300 Billion to build a refinery in the US. A standard, modern greenfield oil refinery in Asia typically costs between $5 billion and $15 billion. However, for massive, highly complex mega-projects integrated with petrochemical plants, the total investment can soar to $20 billion to $44 billion. The America First project is just a vanity project for appearances only.
0 · Reply
Fergus20
Fergus20 Aug. 24 at 12:26 PM
$BCRX kuntstock
0 · Reply
Latest News on BCRX
BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 19 days ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026


BioCryst Pharmaceuticals Earnings release: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 19 days ago

BioCryst Pharmaceuticals Earnings release: Q2 2026


BioCryst Pharmaceuticals Slides: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 19 days ago

BioCryst Pharmaceuticals Slides: Q2 2026


BioCryst Pharmaceuticals Quarterly report: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 19 days ago

BioCryst Pharmaceuticals Quarterly report: Q2 2026


BioCryst Reports Second Quarter 2026 Financial Results

Aug 5, 2026, 7:00 AM EDT - 19 days ago

BioCryst Reports Second Quarter 2026 Financial Results


BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Jul 15, 2026, 7:00 AM EDT - 5 weeks ago

BioCryst Appoints David W. Jenkins as Chief Scientific Officer


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 4 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 4 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 6 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 11 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 1 year ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 1 year ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


Paulzk
Paulzk Aug. 24 at 2:42 PM
$BCRX pennies from heaven
0 · Reply
Pharm_Hand
Pharm_Hand Aug. 24 at 2:37 PM
$BCRX Ghouls and batmen. It's a great chart for Halloween but that's about it.
0 · Reply
WKNDatBERNIES
WKNDatBERNIES Aug. 24 at 1:36 PM
$BCRX up to $10 or down to $9. Either way, let’s get moving
1 · Reply
Paulzk
Paulzk Aug. 24 at 1:07 PM
$BCRX Go gold go!
0 · Reply
buy_undervalued_stocks
buy_undervalued_stocks Aug. 24 at 1:05 PM
$BCRX Down again...
0 · Reply
Paulzk
Paulzk Aug. 24 at 12:57 PM
$BCRX Interesting solar evaluation https://www.youtube.com/watch?v=3MaOu7I2oPc
0 · Reply
BirdStar
BirdStar Aug. 24 at 12:47 PM
1 · Reply
Paulzk
Paulzk Aug. 24 at 12:43 PM
$BCRX 10 billion to build an oil refinery in Asia 300 billion to build a refinery in the US. That is a huge problem. No wonder the construction keeps stalling it makes no economic sense.
1 · Reply
Paulzk
Paulzk Aug. 24 at 12:36 PM
$BCRX To build the refineries we need it would take 19.8 trillion dollars and at least 4 years for each permit approval and 3 to 5 years for the construction. 300 Billion to build a refinery in the US. A standard, modern greenfield oil refinery in Asia typically costs between $5 billion and $15 billion. However, for massive, highly complex mega-projects integrated with petrochemical plants, the total investment can soar to $20 billion to $44 billion. The America First project is just a vanity project for appearances only.
0 · Reply
Fergus20
Fergus20 Aug. 24 at 12:26 PM
$BCRX kuntstock
0 · Reply
Paulzk
Paulzk Aug. 24 at 12:23 PM
$BCRX Gold marches on Spot Gold 4,657.02 +41.30 +0.89%
0 · Reply
Paulzk
Paulzk Aug. 24 at 12:15 PM
$BCRX Can you see the problem here. Just a drop in the bucket to solve the problem. Just , all for show. The United States produces 11.04 million barrels of light crude oil a day. America First Refining's planned facility in Brownsville, Texas, will have a processing capacity of approximately 168,000 barrels of crude oil per day. We would need 66 new refineries like this to refine all US light crude.
0 · Reply
Paulzk
Paulzk Aug. 24 at 12:04 PM
$BCRX (NVDA) Q2 earnings taking center stage on Wednesday. Investors will also be watching a packed slate of software earnings from Salesforce (CRM), CrowdStrike (CRWD), Workday (WDAY), Zoom (ZM) and Intuit before attention turns to Jackson Hole on Friday, where Fed Chair Kevin Warsh is expected to deliver remarks.
0 · Reply
Paulzk
Paulzk Aug. 24 at 11:52 AM
$BCRX A company called Jupiter Brownsville LLC originally developed the project and applied for state permits from the Texas Commission on Environmental Quality (TCEQ) in 2017. Texas issued the permit in 2021. But since then the developers have asked for three extensions to begin construction. https://news.oilandgaswatch.org/post/trump-rebrands-struggling-oil-refinery-project-along-texas-coast-as-america-first-refinery
0 · Reply
Paulzk
Paulzk Aug. 24 at 11:48 AM
$BCRX America First Refining is constructing a massive $300 billion greenfield oil refinery at the Port of Brownsville, Texas. Touted as the first major grass-roots refinery built from scratch in the United States in 50 years, it is specifically designed to process 100% domestic light shale oil.
0 · Reply
Paulzk
Paulzk Aug. 24 at 11:47 AM
$BCRX A project named America First Refining is planned for the port of Brownsville, Texas. Designed to process domestic light shale oil from the Permian Basin, it is slated to begin major assembly by 2028 and full operations by 2029.
0 · Reply
Paulzk
Paulzk Aug. 24 at 11:46 AM
$BCRX The last large "greenfield" crude oil refinery with significant downstream unit capacity built from scratch in the United States was the Marathon Garyville Refinery in Garyville, Louisiana, which came online in 1976 (with initial operations and full scale reaching 1977).
0 · Reply
Paulzk
Paulzk Aug. 24 at 11:26 AM
$BCRX I don't think the US could make up the difference in heavy crude loss if Canada stopped sending the US oil. The US can't refine it's own light crude. Heavy and extra-heavy crude oil reserves are mostly found in Venezuela, Canada, Mexico, Russia, China, Scratch China,Russia and Mexico they don't have extra crude to send us. All we are left with is Venezuela and that's not enough. The US kidnapped Maduro because it needed the heavy crude Venezuela started sending to China. 4 million barrels of heavy crude from Canada creates an existential dependency.
1 · Reply
Paulzk
Paulzk Aug. 24 at 3:05 AM
$BCRX Hawaii and the South East Flood meanwhile the West bakes. Corona California 8 day forcast
0 · Reply
Paulzk
Paulzk Aug. 24 at 2:44 AM
$BCRX For bond fans https://www.youtube.com/watch?v=tdTj59pSEC0
0 · Reply
Paulzk
Paulzk Aug. 24 at 2:42 AM
$BCRX The long term graph of BCRX verses the S&P
2 · Reply
Paulzk
Paulzk Aug. 24 at 2:39 AM
$BCRX BCRX a stock that gives you hope then crushes all hope.
0 · Reply